NHS leaders have warned that the cost of supporting people with ADHD and autism is becoming unsustainable, as a new wave of concerns builds around demand for assessment, treatment and wider services across England. The warning comes amid a growing national debate over how the health service should respond to sharply rising need, with leaders arguing that the current system is under severe strain.
The BMJ reported on September 1, 2026, that NHS leaders described ADHD and autism costs as “out of control,” adding fresh pressure to an already stretched service. The report sits alongside other recent health headlines highlighting the scale of demand on UK care pathways, from record levels of ADHD prescribing to rising complaints from people struggling to access support.
Rising demand is testing NHS capacity
Healthcare leaders say the growth in referrals, diagnoses and follow-up needs is creating a wider operational challenge for services that are already coping with long waiting lists and workforce shortages. The BMJ’s latest news coverage places the issue within a broader discussion about how the NHS can manage complex, long-term neurodevelopmental care without further widening access gaps.
Separate BMJ reporting this year has also highlighted how ADHD is under recognised, underdiagnosed and undertreated in England and the UK, while NHS England has estimated that 2.49 million people in England may have ADHD, including those without a diagnosis. That combination of unmet need and escalating service demand is now central to the debate over future provision.
Pressure is spreading beyond diagnosis alone
The latest concerns are not limited to assessment waiting times. The challenge also covers ongoing support, medication management, education needs and local services for families. BMJ coverage has shown that complaints to NHS services linked to ADHD and autism have risen sharply, with some patients paying thousands of pounds for private treatment when public provision is not available quickly enough.
That picture has fuelled questions about how the NHS should balance clinical need, affordability and capacity. Recent BMJ commentary has argued that the issue is not simply one of rising diagnoses, but of a system struggling to provide timely, coordinated care once concerns are identified.
What happens next for services
For now, the warning from NHS leaders is likely to intensify calls for a clearer national plan on assessment thresholds, support pathways and funding. The debate is expected to remain politically sensitive, because any attempt to limit access risks criticism from families and clinicians, while failing to act could leave services increasingly overstretched.
The latest BMJ reporting suggests the issue is now firmly on the NHS agenda, and likely to remain there as ministers, trusts and clinicians weigh how to respond to one of the fastest-growing areas of demand in mental health and neurodevelopmental care.
Photo source: AI-generated or edited image
